Innoviva (INVA) Interest Coverage Ratio (2010 - 2026)
Innoviva (INVA) posted Interest Coverage Ratio of 1.43 for Q1 2026, up 133.92% on a QoQ basis from 4.23 in Q4 2025, and down 8.94% year-over-year from 1.58 in Q1 2025.
Innoviva (INVA) Interest Coverage Ratio (2010 - 2026) Analysis & Trends
Innoviva's Interest Coverage Ratio history runs 17 years deep, the most recent figure standing at 1.43 for Q1 2026.
- Quarterly Interest Coverage Ratio fell 8.94% year-over-year to 1.43 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 7.44 (down 6.54% YoY) and the FY2025 annual result came in at 3.33, up 274.24% from the prior year.
- Interest Coverage Ratio was 1.43 for Q1 2026 at Innoviva, up from 4.23 in the prior quarter.
- Across five years, Interest Coverage Ratio topped out at 9.94 in Q3 2023 and bottomed at 6.58 in Q2 2022.
- A 5-year average of 1.09 and a median of 0.04 in 2023 frame the typical range for Interest Coverage Ratio.
- Annual changes were most pronounced in 2024 — Interest Coverage Ratio slumped 5323.28% — and 2025, when it soared 341.82%.
- Innoviva's Interest Coverage Ratio stood at 1.85 in 2022, then jumped by 97.9% to 0.04 in 2023, then slumped by 5323.28% to 2.11 in 2024, then slumped by 100.61% to 4.23 in 2025, then jumped by 133.92% to 1.43 in 2026.
- Business Quant data shows INVA's Interest Coverage Ratio at 1.43 in Q1 2026, 4.23 in Q4 2025, and 9.32 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | Innoviva | 1.57 Bn | 969.11 Mn | 75.83 Mn | 1.43 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.43 |
| Dec 31, 2025 | -4.23 |
| Sep 30, 2025 | 9.32 |
| Jun 30, 2025 | 1.85 |
| Mar 31, 2025 | 1.58 |
| Dec 31, 2024 | -2.11 |
| Sep 30, 2024 | 7.09 |
| Jun 30, 2024 | 2.12 |
| Mar 31, 2024 | -0.65 |
| Dec 31, 2023 | -0.04 |
| Sep 30, 2023 | 9.94 |
| Jun 30, 2023 | -1.21 |
| Mar 31, 2023 | -1.41 |
| Dec 31, 2022 | -1.85 |
| Sep 30, 2022 | 6.10 |
| Jun 30, 2022 | -6.58 |
| Mar 31, 2022 | -2.74 |
| Dec 31, 2021 | -0.16 |
| Sep 30, 2021 | 19.02 |
| Jun 30, 2021 | 2.22 |